Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Change in Receivables: 2013-2024

Historic Change in Receivables for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to -$40,000.

  • vTv Therapeutics' Change in Receivables fell 276.47% to -$180,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$40,000, marking a year-over-year decrease of 260.00%. This contributed to the annual value of -$40,000 for FY2024, which is 43.66% up from last year.
  • According to the latest figures from FY2024, vTv Therapeutics' Change in Receivables is -$40,000, which was up 43.66% from -$71,000 recorded in FY2023.
  • Over the past 5 years, vTv Therapeutics' Change in Receivables peaked at $153,000 during FY2020, and registered a low of -$101,000 during FY2021.
  • Moreover, its 3-year median value for Change in Receivables was -$40,000 (2024), whereas its average is $1,667.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 2,960.00% in 2020, then plummeted by 166.01% in 2021.
  • vTv Therapeutics' Change in Receivables (Yearly) stood at $153,000 in 2020, then plummeted by 166.01% to -$101,000 in 2021, then soared by 214.85% to $116,000 in 2022, then tumbled by 161.21% to -$71,000 in 2023, then surged by 43.66% to -$40,000 in 2024.